Report an accessibility problem

Technology Transfer at NIH --Lecture Alert

January 14, 2020

Technology Transfer at NIH: How a US
Government Agency’s Conventional Basic Research-
Focused Endeavors Have Resulted in Innovative Public Health Breakthroughs

Date: January 28th, 2020

Time:  10:45 am - 11:30 am

Location:

Biodesign Institute -- Auditorium B105

727 E Tyler St, Tempe, AZ, 85287

Abstract:

The American scientific community has long recognized the importance of public funding support for basic research as being critical to the US innovation ecosystem and overall economy. Less appreciated is the role of academic and government technology transfer efforts to bridge the gaping “valley of death” divide that exists, particularly in the life sciences and pharmaceutical drug development arenas, between early-stage research and the eventual successful commercialization of government and academic inventions. In this talk Ms. Driscoll will discuss how NIH has thrived as an catalyst for the creation of new companies, products and even entirely new industries within the life sciences sector as both 1) a significant funder of research and a developer of key research policies (such as data sharing); 2) an organization with its own highly productive and innovative research program despite the fact that NIH’s in-house (intramural) technology transfer offices cannot spin-out companies, run proof-of-concept funds or set up incubators—we can only collaborate with companies and out-license our inventions.

Speaker:

Claire Driscoll has served as the Director of the National Human Genome Research Institute (NHGRI)'s Technology Transfer Office (TTO) since 2002. In this capacity Ms. Driscoll is responsible for the overall oversight of the Institute's intramural patent and licensing portfolio, and she advises staff on technology transfer policy and related matters. The TTO also negotiates and manages research collaboration agreements on behalf of NHGRI scientists. From 1999 through 2002 Ms. Driscoll was the Associate Director of NHGRI's Technology Transfer Office. Prior to joining NHGRI Claire spent almost five years as a Senior Technology Development Manager with the NIH's National Institute of Allergy and Infectious Diseases (NIAID). Earlier in her career she spent four years working as a biologist in a National Institute of

Child Health and Human Development (NICHD) laboratory at NIH.

 

Please RSVP by January 28th, 2020.